Following on from our webinar on The Estrobolome and Menopause: Gut Health, the Microbiome and Nutrition, presented by Dr Linia Patel (PhD), RD, we’ve pulled together some of the key resources and references discussed within the webinar, we’ve pulled together some of the key resources and references discussed within the webinar.
The resources below are organised by topic to support further reading and evidence-based nutrition practice.
If you missed the live webinar, you can register to watch the recording.
Clinical Guidelines
National Institute for Health and Care Excellence (NICE). Menopause: Identification and Management (NG23). NICE; 2015, updated 2026.
National Institute for Health and Care Excellence (NICE). Urinary Tract Infection (Recurrent): Antimicrobial Prescribing (NG112). NICE; 2018, updated 2024.
National Institute for Health and Care Excellence (NICE). Irritable Bowel Syndrome in Adults: Diagnosis and Management (CG61). NICE; 2008.
Scientific Advisory Committee on Nutrition (SACN). Carbohydrates and Health. Public Health England; 2015.
Key Studies – The Estrobolome and Oestrogen Metabolism
Liaquat M, Minihane AM, Vauzour D, Pontifex MG. The gut microbiota in menopause: Is there a role for prebiotic and probiotic solutions? Post Reprod Health. 2025;31(2):105–114. doi:10.1177/20533691251340491
Peters BA, et al. Menopause is associated with an altered gut microbiome and estrobolome, with implications for adverse cardiometabolic risk in the Hispanic Community Health Study/Study of Latinos. mSystems. 2022;7(3):e00273-22. doi:10.1128/msystems.00273-22
Key Studies – The Vaginal Microbiome and Genitourinary Health
Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42–50. doi:10.1016/j.maturitas.2016.05.015
Pavlovska O, Savelyeva O, Pavlovska K. Genitourinary syndrome of menopause and intestinal microbiota. Prz Menopauzalny. 2023;22(4):213–219. doi:10.5114/pm.2023.133828
Zeng Q, et al. Associations of vaginal microbiota with the onset, severity, and type of symptoms of genitourinary syndrome of menopause in women. Front Cell Infect Microbiol. 2024;14:1402389. doi:10.3389/fcimb.2024.1402389
Graham ME, et al. Gut and vaginal microbiomes on steroids: Implications for women’s health. Trends Endocrinol Metab. 2021;32(8).
Key Studies – Gastrointestinal Symptoms and Menopause
Lenhart A, Naliboff B, Shih W, et al. Postmenopausal women with irritable bowel syndrome (IBS) have more severe symptoms than premenopausal women with IBS. Neurogastroenterol Motil. 2020;32(10):e13913. doi:10.1111/nmo.13913
Mulak A, Taché Y, Larauche M. Sex hormones in the modulation of irritable bowel syndrome. World J Gastroenterol. 2014;20(10):2433–2448. doi:10.3748/wjg.v20.i10.2433
Denby N. Menopause and the gut: Uncovering a hidden health burden. Menopause. 2025;32:1205. Abstract P-36. doi:10.1097/GME.0000000000002706
Key Studies – Probiotics and Constipation
Nakapun N, Boonyanurak P. Effect of multi-strain probiotics on constipation and quality of life in menopausal women: A double-blind, randomized, placebo-controlled, single-center trial. Thai J Obstet Gynaecol. 2026;34:204–216. doi:10.66650/tjog.v34i3.277495
Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236–251. doi:10.1080/19490976.2017.1412908
Food for Menopause Book
Food for Menopause: Recipes and nutritional advice for perimenopause, menopause and beyond. 2024. Dr Linia Patel.

Other key resources
Speaker – Dr Linia Patel

Dr Linia Patel
Women’s Health Dietitian & Performance Nutritionist
About Optibac – Webinar Partner
About Optibac
Optibac are experts and leaders in the market of probiotics in UK and Ireland. With 2 decades of expertise specialising entirely in probiotics formulations, they understand the importance of strain specificity, a fact recognised by WHO and IPA. This acknowledgement drives Optibac to partner with leading microbial institutes worldwide and work with some of the most extensively researched strains available, reflecting the company’s commitment to quality. Every Optibac strain undergoes rigorous testing to ensure they reach the gut alive. Education is another cornerstone of their values.
YOU MAY ALSO BE INTERESTED IN:
Chronic Constipation *New* BDA Dietary Guidelines
IBS and IBD Overlap in Clinical Practice: The Role of the Gut Microbiome and Probiotics
More than Medication: Optimising Weight Loss Drug Outcomes in Practice





